Turn Biotechnologies
PrivateLast Round
M&A
May 21, 2026
Est. Valuation
$59M
Total Funding Raised
$30.1M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Turn Biotechnologies is a biotechnology company that develops mRNA-based therapies to repair and rejuvenate tissue at the cellular level by reprogramming the epigenome.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Turn Biotechnologies Comparables
Compare Turn Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rejuvenation Technologies | 80% | |
| Oisín Biotechnologies | 79% | |
| Altos Labs | 78% |
Turn Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | May 21, 2026 | ||||
| Series A | Sep 6, 2023 | ||||
| Grant | Jul 21, 2022 | ||||
| Seed | Apr 11, 2022 | ||||
| Seed | Apr 28, 2021 |
Key People
Founding team and executive leadership
Turn Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Khosla Ventures | Seed, Series A |
| VitaDAO | Grant |
| LongeVC | Seed |
| ThreeD Capital | Seed |
| Vitality Healthspan Foundation | Seed |
| Astellas Venture Management | Series A, Seed |
| Shanda Group | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 21, 2026
Daewoong Pharmaceutical participated in the M&A round.
- Sep 30, 2025
Select assets acquired for $300M, anchored by pharma partnership.
Turn Biotechnologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Turn Biotechnologies's valuation, stock price, and market status.
Is turn.bio a public or private company?
turn.bio is a private company.
What is the current stock price of turn.bio?
turn.bio is a private company with no public stock price. No recent secondary market data is available.
How much is turn.bio worth (valuation)?
Valuation information for turn.bio is not publicly available.
Can I buy turn.bio stock?
turn.bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was turn.bio's last funding round?
turn.bio's most recent funding round was Series A on September 6, 2023.
Who are the main investors in turn.bio?
Key investors in turn.bio include Astellas Venture Management.
Will turn.bio IPO soon?
No public IPO plans have been announced for turn.bio.
How can I track turn.bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor turn.bio's secondary market activity and sign up for updates.